Figure 3From: Protonated nanostructured aluminosilicate (NSAS) reduces plasma cholesterol concentrations and atherosclerotic lesions in Apolipoprotein E deficient mice fed a high cholesterol and high fat dietWeekly food in-take (Mean +/- SEM) from the beginning of the treatment (week 0) in the Apo-E deficient mice treated with 1.4% w/w (n = 8) of protonated NSAS, 2% w/w stigmastanol (n = 7) vs. untreated control (n = 8). No statistically significant differences between treatment and untreated control groups were observed. SEM were not shown in this figure.Back to article page